Activest Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.52K Sell
15
-197
-93% -$94.6K ﹤0.01% 640
2026
Q1
$104K Buy
212
+93
+78% +$50.5K 0.02% 228
2025
Q4
$69K Sell
119
-27
-18% -$15.3K 0.01% 274
2025
Q3
$70.8K Buy
146
+58
+66% +$27K 0.01% 221
2025
Q2
$35.7K Buy
88
+74
+529% +$30.9K 0.01% 248
2025
Q1
$6.97K Buy
14
+12
+600% +$6.5K ﹤0.01% 462
2024
Q4
$1.04K Buy
2
+1
+100% +$550 ﹤0.01% 461
2024
Q3
$568 Sell
1
-21
-95% -$12.4K ﹤0.01% 479
2024
Q2
$12.2K Hold
22
﹤0.01% 289
2024
Q1
$12.8K Hold
22
0.01% 203
2023
Q4
$11.7K Buy
+22
New +$10.6K 0.01% 186
2023
Q1
Sell
-6
Closed -$3.3K 539
2022
Q4
$3.3K Buy
+6
New +$3.18K ﹤0.01% 380
2022
Q1
Sell
-6
Closed -$4K 375
2021
Q4
$4K Hold
6
﹤0.01% 274
2021
Q3
$3K Hold
6
﹤0.01% 320
2021
Q2
$3K Hold
6
﹤0.01% 290
2021
Q1
$3K Buy
+6
New +$2.86K ﹤0.01% 266

Other funds holding TMO

Activest Wealth Management's TMO Position: Q2 2026 in Review

Activest Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 93% in Q2 2026, selling an estimated $94.6K and leaving 15 shares worth $7.52K. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Activest Wealth Management first reported a position in TMO in Q1 2021 and has held it in 16 quarters since. The position peaked at $104K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Activest Wealth Management held 15 shares of Thermo Fisher Scientific worth $7.52K as of Q2 2026.
  • Activest Wealth Management sold 197 Thermo Fisher Scientific shares in Q2 2026, an estimated $94.6K.
  • Thermo Fisher Scientific made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #640 holding.
  • Activest Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 16 quarters since.
  • Activest Wealth Management's Thermo Fisher Scientific position peaked at $104K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.